Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
dc.contributor.author | Salih, Niven A | |
dc.contributor.author | van Griensven, Johan | |
dc.contributor.author | Chappuis, François | |
dc.contributor.author | Antierens, Annick | |
dc.contributor.author | Mumina, Ann | |
dc.contributor.author | Hammam, Omar | |
dc.contributor.author | Boulle, Philippa | |
dc.contributor.author | Alirol, Emilie | |
dc.contributor.author | Alnour, Mubarak | |
dc.contributor.author | Elhag, Mousab S | |
dc.contributor.author | Manzi, Marcel | |
dc.contributor.author | Kizito, Walter | |
dc.contributor.author | Zachariah, Rony | |
dc.date.accessioned | 2014-03-24T21:59:28Z | |
dc.date.available | 2014-03-24T21:59:28Z | |
dc.date.issued | 2014-02 | |
dc.identifier.citation | Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? 2014, 19 (2):146-52 Trop. Med. Int. Health | en_GB |
dc.identifier.issn | 1365-3156 | |
dc.identifier.pmid | 24433217 | |
dc.identifier.doi | 10.1111/tmi.12238 | |
dc.identifier.uri | http://hdl.handle.net/10144/314577 | |
dc.description.abstract | The aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan. | |
dc.language.iso | en | en |
dc.publisher | John Wiley & Sons Ltd | en_GB |
dc.rights | Archived on this site with the kind permission of Wiley-Blackwell, [url]http://www.blackwell-synergy.com/loi/tmi[/url] | en_GB |
dc.subject | Kala Azar/Visceral Leishmaniasis | en_GB |
dc.subject | Operational Research | en_GB |
dc.subject.mesh | Adolescent | en_GB |
dc.subject.mesh | Adult | en_GB |
dc.subject.mesh | Amphotericin B | en_GB |
dc.subject.mesh | Child | en_GB |
dc.subject.mesh | Child, Preschool | en_GB |
dc.subject.mesh | Female | en_GB |
dc.subject.mesh | HIV Infections | en_GB |
dc.subject.mesh | Humans | en_GB |
dc.subject.mesh | Infant | en_GB |
dc.subject.mesh | Leishmania donovani | en_GB |
dc.subject.mesh | Leishmaniasis, Visceral | en_GB |
dc.subject.mesh | Lost to Follow-Up | en_GB |
dc.subject.mesh | Male | en_GB |
dc.subject.mesh | Middle Aged | en_GB |
dc.subject.mesh | Neglected Diseases | en_GB |
dc.subject.mesh | Pregnancy | en_GB |
dc.subject.mesh | Pregnancy Complications, Parasitic | en_GB |
dc.subject.mesh | Recurrence | en_GB |
dc.subject.mesh | Sudan | en_GB |
dc.subject.mesh | Treatment Failure | en_GB |
dc.subject.mesh | Treatment Outcome | en_GB |
dc.subject.mesh | Trypanocidal Agents | en_GB |
dc.subject.mesh | Young Adult | en_GB |
dc.title | Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease? | en |
dc.identifier.journal | Tropical Medicine & International Health : TM & IH | en_GB |
refterms.dateFOA | 2019-03-04T11:06:57Z | |
html.description.abstract | The aim of this study was to report the patient profile and treatment outcomes, including relapses, of patients with visceral leishmaniasis (VL) treated with liposomal amphotericin B (AmBisome) in Gedaref, Sudan. |